Home › Entities › academia › Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective

Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective

Research article (Journal of Managed Care & Specialty Pharmacy, 2021) · cited 11× · AI/ML
academia openalex:W3215200126
Press Enter · cited answer in seconds

Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: an US societal perspective

Summary

Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: an US societal perspective is a scholarly article[1].

Key Facts

  • Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: an US societal perspective's instance of is recorded as scholarly article[2].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective. Retrieved May 24, 2026, from https://4ort.xyz/entity/costs-associated-with-the-administration-of-erythropoiesis-stimulating-agents-for-the-treatment-of-anemia-in-patients-wi
MLA “Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/costs-associated-with-the-administration-of-erythropoiesis-stimulating-agents-for-the-treatment-of-anemia-in-patients-wi.
BibTeX @misc{4ortxyz_costs-associated-with-the-administration-of-erythropoiesis-stimulating-agents-for-the-treatment-of-anemia-in-patients-wi_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective}}, year = {2026}, url = {https://4ort.xyz/entity/costs-associated-with-the-administration-of-erythropoiesis-stimulating-agents-for-the-treatment-of-anemia-in-patients-wi}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective — https://4ort.xyz/entity/costs-associated-with-the-administration-of-erythropoiesis-stimulating-agents-for-the-treatment-of-anemia-in-patients-wi (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/costs-associated-with-the-administration-of-erythropoiesis-stimulating-agents-for-the-treatment-of-anemia-in-patients-wi · Last refreshed: